Thus, an exogenous activator of the PIKfyve complex, expected to be beneficial in PIKfyve associated genetic diseases, may also be effective in Alzheimer's disease. The gene discussed is PIKFYVE; the disease is early-onset autosomal dominant Alzheimer disease.